Managing type 2 diabetes is already a challenge, and starting Ozempic can bring new concerns. While stomach issues like nausea are widely known, some people also report changes in mood and thinking.
Studies and patient reports point to possible links between Ozempic and symptoms such as depression, anxiety, and brain fog. Even if these effects are less common than digestive problems, they can affect daily life and raise serious questions for patients.
This article explains what research has found, what real users have experienced, and what you can do if you notice mental side effects while on Ozempic.
What are the known side effects of taking Ozempic?
Some of the frequently reported side effects of Ozempic include:
Can Ozempic cause mental side effects?

Based on current studies and regulator reviews, there’s no confirmed causal link between Ozempic and mental health harms like depression or suicidal thoughts. A large electronic-health-record analysis reported no increase, and possibly a lower risk, of suicidal ideation with semaglutide compared with other agents.
However, findings from safety surveillance were not the same. Two widely referenced studies used adverse event reporting databases.
One study looked at the European database that collects reports of side effects from medicines. Between January 2021 and May 2023, there were more than 31,000 total reports from people taking Ozempic and other GLP-1 medications.
About 1.2% (372 cases) involved mental health concerns. Of these:
-
- 50% were depression
- 39% were anxiety
- Nearly 20% were suicidal thoughts
Another study used the World Health Organization’s global side effects database, covering 2000 to August 2023. It found 107 cases tied to semaglutide. When compared with other diabetes drugs like metformin and dapagliflozin, semaglutide still showed a higher rate of reports for suicidal thoughts.
These findings do not prove that Ozempic causes depression or suicide. But they do suggest the issue should be studied more closely. Because of this, Novo Nordisk, the maker of Ozempic, advises doctors to warn patients to watch for depression, suicidal thoughts, or any sudden mood changes.
Why do some people experience mental side effects on Ozempic?
While a direct cause hasn’t been proven, researchers and clinicians have proposed several possible explanations, including:
1. Biological effects on brain signaling
GLP-1 receptors aren’t just found in the gut. They’re also present in the brain, in regions that control appetite, reward, stress, and mood. Animal studies show that some GLP-1 drugs, including liraglutide, semaglutide, and exenatide, can even cross the blood-brain barrier, the protective filter that normally blocks many substances from entering the brain.
Brain imaging research has found that these medications may change how brain regions communicate with each other, suggesting they are indeed active in the central nervous system.
Because of this, Ozempic may not only influence physical health but could also impact mood. In fact, some research points to possible benefits.
A recent study suggests that diabetes and mood disorders are closely linked, where each one can raise the risk of the other. This is thought to be partly due to inflammation in the brain and body.
Using an animal model of diabetes, they studied the prefrontal cortex, a brain area tied to thinking, decision-making, and emotions, often affected in both diabetes and depression. They looked at brain chemicals and markers linked to neuroinflammation and nerve health. They also checked how semaglutide influenced inflammation in the rest of the body and measured stress responses.
Results showed that semaglutide improved both behavioral signs of anxiety and depression in diabetic mice. It also reduced neuroinflammation and improved brain health markers.
2. Low blood sugar from other diabetes drugs
Ozempic on its own rarely causes low blood sugar. But if you’re also taking insulin or a sulfonylurea, your blood sugar can drop too low. When that happens, the brain doesn’t get enough glucose, which can cause symptoms, such as:
-
- confusion
- drowsiness
- irritability
- anxiety
- headaches
These can feel like mental health issues, but they’re actually signs of low blood sugar.
A study found that as blood sugar dropped in people with diabetes, overall mood got worse. Anger increased significantly once glucose fell to 2.5 mmol/L. People who already scored higher for hostility on personality tests were more likely to get angrier when their blood sugar went low.
That’s why, if you start Ozempic while still using insulin or a sulfonylurea, your doctor may need to adjust your doses to keep you safe.
3. Rapid weight loss and nutrition gaps
Ozempic may reduce appetite, which helps with weight loss and blood sugar control. But when your appetite drops a lot, you may eat fewer calories than your body needs, and miss out on protein or essential vitamins and minerals.
A study showed that a lack of certain nutrients can affect how the brain and nervous system work. These include:
-
- Protein
- B vitamins
- Vitamin D
- Magnesium
- Zinc
- Selenium
- Iron
- Calcium
- Omega-3 fatty acids
These shortages may increase the chance of developing depressive symptoms.
An analysis using data from the National Health and Nutrition Examination Survey (NHANES) found that poor nutrition and depression are closely linked. Having multiple nutrient deficiencies seems to make depression more likely or more severe.
Poor sleep during this adjustment can add to the problem. These effects are most common in the early stages of treatment and often ease once nutrition is balanced and weight loss slows to a steadier, more sustainable pace.
4. Existing mental health vulnerabilities
If you already live with depression, anxiety, or another mood disorder, even small changes in brain chemistry, sleep, appetite, or blood sugar can have a bigger emotional impact. In addition, some antidepressants or anti-anxiety medicines may overlap in how they affect neurotransmitters or metabolism, which can complicate how your body reacts to Ozempic.
In a case report, a 40-year-old woman with a long history of major depressive disorder was prescribed semaglutide by her endocrinologist in March 2023 to help manage both blood sugar and weight. She began with 0.25 mg weekly and later increased to 0.5 mg.
By late April, her depression began to worsen. In May, she developed fatigue, slowed thinking, oversleeping, and suicidal thoughts, similar to her past depressive episodes. These symptoms appeared even though she had been doing well with therapy before. She also faced family stress during this time, but stress alone had never triggered such a severe decline.
When semaglutide was stopped, her mood started to improve within two weeks.
Another report was from a 54-year-old woman with diabetes, high blood pressure, high cholesterol, and a past history of depression. Her blood sugar had been hard to control even with the maximum dose of metformin, and her A1C was 9.2%. After talking through options, her doctor added Ozempic 0.5 mg weekly to her treatment.
She tolerated the drug well, and her A1C dropped to 8.5% after four weeks. But she also began noticing changes in her mood. She felt more irritable and anxious, had trouble sleeping, and lost interest in activities she normally enjoyed. The symptoms lasted for two weeks and started interfering with her daily life.
Since the timing lined up with starting Ozempic, and she had a past history of depression, they chose to stop Ozempic and switch her to a different medication. Over the next several weeks, her mood improved, and she reported feeling more like herself again.
But this doesn’t mean you can’t take Ozempic if you have a mental health history. Instead, you should:
-
- Tell your doctor about your mental health background.
- Watch for mood changes (low mood, brain fog, irritability, anxiety, or suicidal thoughts).
- Get support early if symptoms show up.
What do patients say about Ozempic and mental side effects?

Researchers analyzed over 43,000 posts and comments from Reddit, YouTube, and TikTok to see how people online were describing the mental health effects of GLP-1 drugs.
Here’s what they found:
-
- Sleep issues were the most common topic (620 mentions of insomnia).
-
- Other frequent mentions were anxiety (353), depression (204), and mental health in general (165).
- People described a mixed experience:
-
-
-
- Some reported feeling better mood, less anxiety, and better control of addictive behaviors after starting a GLP-1 drug.
-
-
-
-
-
- Others described worsening mood, new anxiety, or more trouble sleeping.
-
-
This is the first study to document how people on social media talk about the mental health effects of GLP-1 drugs like Ozempic. The results show that experiences are not the same for everyone. For some, mental health improves, while for others, it declines.
Positive experiences with Ozempic:
Negative experiences with Ozempic:
What should you do if you experience mental side effects on Ozempic?
If you notice mood changes, anxiety, brain fog, or depression-like symptoms after starting Ozempic, there are steps you can take to address them.
Final Thoughts
Mental side effects from Ozempic are less clear. Research hasn’t confirmed that Ozempic causes depression or suicidal thoughts, but some reports and case studies suggest mood changes, anxiety, or sleep problems can occur in certain people.
Some people feel better mentally on Ozempic, while others feel worse. That’s why it’s important to pay attention to your own symptoms, track any changes, and bring them to your doctor. If mood issues interfere with your daily life, a medical review is needed. And if you ever think about harming yourself, call 988 or 911 for emergency help.
Related Articles
Frequently Asked Questions
Sources
Smits, M. M., & Van Raalte, D. H. (2021). Safety of semaglutide. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.645563
Schoretsanitis, G., Weiler, S., Barbui, C., Raschi, E., & Gastaldon, C. (2024). Disproportionality analysis from World Health Organization data on semaglutide, liraglutide, and suicidality. JAMA Network Open, 7(8), e2423385. https://doi.org/10.1001/jamanetworkopen.2024.23385
Tobaiqy, M., & Elkout, H. (2024). Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database. International Journal of Clinical Pharmacy, 46(2), 488–495. https://doi.org/10.1007/s11096-023-01694-7
Wang, W., Volkow, N. D., Berger, N. A., Davis, P. B., Kaelber, D. C., & Xu, R. (2024). Association of semaglutide with risk of suicidal ideation in a real-world cohort. Nature Medicine, 30(1), 168–176. https://doi.org/10.1038/s41591-023-02672-2
West, J., Li, M., Wong, S., Le, G. H., Teopiz, K. M., Valentino, K., Dri, C. E., & McIntyre, R. S. (2025). Are Glucagon-Like peptide-1 (GLP-1) receptor agonists central nervous system (CNS) penetrant: A Narrative review. Neurology and Therapy. https://doi.org/10.1007/s40120-025-00724-y
Pi?tkowska-Chmiel, I., Wicha-Komsta, K., Paw?owski, K., Syrytczyk, A., Kocki, T., Dudka, J., & Herbet, M. (2025). Beyond Diabetes: Semaglutide’s Role in Modulating Mood Disorders through Neuroinflammation Pathways. Cellular and Molecular Neurobiology, 45(1). https://doi.org/10.1007/s10571-025-01534-4
Merbis, M., Snoek, F., Kanc, K., & Heine, R. (1996). Hypoglycaemia induces emotional disruption. Patient Education and Counseling, 29(1), 117–122. https://doi.org/10.1016/0738-3991(96)00940-8
Zieli?ska, M., ?uszczki, E., & Dere?, K. (2023). Dietary nutrient deficiencies and risk of Depression (Review article 2018–2023). Nutrients, 15(11), 2433. https://doi.org/10.3390/nu15112433
Owczarek, M., Jurek, J., Nolan, E., & Shevlin, M. (2022). Nutrient deficiency profiles and depression: A latent class analysis study of American population. Journal of Affective Disorders, 317, 339–346. https://doi.org/10.1016/j.jad.2022.08.100
Li, J., Cao, J., Wei, J., & Geng, W. (2023). Case Report: Semaglutide-associated depression: a report of two cases. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1238353
Arillotta, D., Floresta, G., Guirguis, A., Corkery, J. M., Catalani, V., Martinotti, G., Sensi, S. L., & Schifano, F. (2023). GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. Brain Sciences, 13(11), 1503. https://doi.org/10.3390/brainsci13111503
Manoharan, S. V. R. R., & Madan, R. (2024). GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide). Innovations in clinical neuroscience, 21(4-6), 25–26. https://pmc.ncbi.nlm.nih.gov/articles/PMC11208009/




